BridgeBio Pharma, Inc. Common Stock
$67.31
Market Cap
$13.35B
Shares Outstanding
195.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 27, 2019
Round Lot
100
Locale
US
Day Open
$69.72
Day High
$69.99
Day Low
$66.93
Volume
2.34M
VWAP
$67.52
Prev Close
$68.30
Transactions
--
Acc. Volume
--
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
BridgeBio Pharma, Inc. Common Stock (BBIO) closed the 2026-09-17 session at $67.31, down 1.45% versus the previous close (-0.99). The stock opened at $69.72 and traded between $66.93 and $69.99 during that session. Session trading volume was 2.3M shares. The volume-weighted average price (VWAP) is $67.52.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
BridgeBio Pharma, Inc. Common Stock has a market capitalization of $13.35 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. BBIO is listed on the XNAS exchange. The company employs approximately 839 people. BridgeBio Pharma, Inc. Common Stock is headquartered in PALO ALTO, CA. The recorded listing date is 2019-06-27.
On this page you can find market BBIO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.